Hysteropexy inferior to Manchester Procedure for Uterine Descent: JAMA
Written By : Jacinthlyn Sylvia
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2023-08-29 14:45 GMT | Update On 2023-08-29 14:45 GMT
Advertisement
The findings published in the Journal of American Medical Association found that sacrospinous hysteropexy demonstrates inferiority compared to the Manchester procedure.
Pelvic organ prolapse, a condition in which the uterus or other organs descend into the vaginal canal, often necessitates surgical intervention. Sacrospinous hysteropexy, the prevailing uterus-preserving approach, has dominated the field. However, the older Manchester procedure still holds ground as an alternative technique. So, Enklaar Rosa and team conducted this randomized clinical trial across 26 hospitals in the Netherlands on the comparative effectiveness of two popular surgical techniques: sacrospinous hysteropexy and the Manchester procedure.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.